Drug Type Prophylactic vaccine, Genetically engineered subunit vaccine |
Synonyms CoV-RBD121-NP, KBP-201 |
Target |
Mechanism SARS-CoV-2 S protein inhibitors(Coronavirus spike glycoprotein inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Phase 2 | US | 30 Dec 2020 | |
COVID-19 | Phase 2 | CA | 30 Dec 2020 |